论文部分内容阅读
1商品名 Synagis2 开发与上市厂商 (美)Medimmune公司研制,Abbott公司上市。1998年首次在美国上市,1999年11月在英国上市,2000年3月在西班牙上市。3药效分类 免疫激动剂4药理 呼吸道合胞病毒是导致婴幼儿下呼吸道感染及免疫缺陷性疾病的重要原因,对呼
1 Name Synagis2 Developed and Listed Manufacturer (US) Developed by Medimmune Inc., Abbott Public Limited. First listed in the United States in 1998, in the UK in November 1999 and in March 2000 in Spain. 3 Pharmacodynamic classification Immunostimulant 4 Pharmacology Respiratory syncytial virus is an important cause of infantile lower respiratory tract infection and immunodeficiency diseases,